Alon Lazarus - Net Worth and Insider Trading
Alon Lazarus Net Worth
The estimated net worth of Alon Lazarus is at least $132 Million dollars as of 2024-11-13. Alon Lazarus is the Director, 10% Owner of Keros Therapeutics Inc and owns about 2,036,140 shares of Keros Therapeutics Inc (KROS) stock worth over $132 Million. Details can be seen in Alon Lazarus's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alon Lazarus has not made any transactions after 2020-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alon Lazarus
Alon Lazarus Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alon Lazarus owns 2 companies in total, including Keros Therapeutics Inc (KROS) , and Werewolf Therapeutics Inc (HOWL) .
Click here to see the complete history of Alon Lazarus’s form 4 insider trades.
Insider Ownership Summary of Alon Lazarus
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2020-04-13 | director & 10 percent owner |
| HOWL | Werewolf Therapeutics Inc | 2021-04-29 | director & 10 percent owner |
Alon Lazarus Latest Holdings Summary
Alon Lazarus currently owns a total of 1 stock. Alon Lazarus owns 2,036,140 shares of Keros Therapeutics Inc (KROS) as of April 13, 2020, with a value of $132 Million.
Latest Holdings of Alon Lazarus
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2020-04-13 | 2,036,140 | 64.80 | 131,941,872 |
Holding Weightings of Alon Lazarus
Alon Lazarus Form 4 Trading Tracker
According to the SEC Form 4 filings, Alon Lazarus has made a total of 1 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Keros Therapeutics Inc is the acquisition of 120,000 shares on April 13, 2020, which cost Alon Lazarus around $2 Million.
Insider Trading History of Alon Lazarus
- 1
Alon Lazarus Trading Performance
GuruFocus tracks the stock performance after each of Alon Lazarus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alon Lazarus is 32.59%. GuruFocus also compares Alon Lazarus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alon Lazarus within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alon Lazarus's insider trading performs compared to the benchmark.
Performance of Alon Lazarus
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.76 | | | | | |
| Relative Return to S&P 500(%) | 21.65 | | | | | |
Alon Lazarus Ownership Network
Ownership Network List of Alon Lazarus
Ownership Network Relation of Alon Lazarus
Alon Lazarus Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Alon Lazarus is the director & 10 percent owner of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Alon Lazarus made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 250,000 shares made by Carl L Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 580,000 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Alon Lazarus Mailing Address
Above is the net worth, insider trading, and ownership report for Alon Lazarus. You might contact Alon Lazarus via mailing address: C/o Keros Therapeutics, Inc., 99 Hayden Avenue, Suite 120, Building E, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
